| __timestamp | ADMA Biologics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 11768000 |
| Thursday, January 1, 2015 | 7015946 | 15152000 |
| Friday, January 1, 2016 | 7688238 | 19828000 |
| Sunday, January 1, 2017 | 6229587 | 25573000 |
| Monday, January 1, 2018 | 3926120 | 23634000 |
| Tuesday, January 1, 2019 | 2343848 | 38845000 |
| Wednesday, January 1, 2020 | 5907013 | 50523000 |
| Friday, January 1, 2021 | 3646060 | 75463000 |
| Saturday, January 1, 2022 | 3613764 | 105767000 |
| Sunday, January 1, 2023 | 3300000 | 167512000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc. have demonstrated contrasting strategies in their R&D expenditures.
From 2014 to 2023, ADMA Biologics, Inc. saw a gradual decline in R&D spending, starting at approximately $9.5 million in 2014 and dropping to around $3.3 million by 2023. This represents a decrease of over 65%, reflecting a strategic shift or potential resource reallocation.
Conversely, Xenon Pharmaceuticals Inc. has significantly ramped up its R&D investments, increasing from about $11.8 million in 2014 to a staggering $167.5 million in 2023. This 14-fold increase underscores Xenon's commitment to pioneering new treatments and therapies.
These divergent paths highlight the varied approaches companies take in navigating the competitive biotech landscape.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.